Bearish Chart Formation for Innophos Holdings, Inc. (IPHS) After Forming Bearish Double Bottom Chart Pattern

September 17, 2017 - By Henry Gaston

Investors sentiment decreased to 1.06 in Q4 2016. Its down 0.24, from 1.3 in 2016Q3. It fall, as 14 investors sold Innophos Holdings, Inc. shares while 69 reduced holdings. 34 funds opened positions while 54 raised stakes. 17.78 million shares or 0.01% more from 17.78 million shares in 2016Q3 were reported.
Kestrel Inv Corp reported 122,400 shares stake. Mawer Mgmt Ltd invested 0.19% in Innophos Holdings, Inc. (NASDAQ:IPHS). Bogle Management Limited Partnership De stated it has 79,205 shares. Citadel Advisors Limited Liability owns 36,259 shares for 0% of their portfolio. Century Cos Inc stated it has 278,308 shares or 0.02% of all its holdings. Bridgeway Capital Management reported 10,250 shares. Kanaly Trust Co has 91 shares. Cubist Systematic Strategies Ltd Limited Liability Company invested in 5,258 shares. Verition Fund Mngmt Ltd Llc holds 5,560 shares. Secor Ltd Partnership stated it has 25,395 shares or 0.16% of all its holdings. Axa has 32,900 shares. State Bank Of America De owns 108,159 shares or 0% of their US portfolio. Connor Clark Lunn Investment Mngmt Ltd accumulated 11,900 shares. Paradigm Asset Management Ltd Llc invested in 3,800 shares or 0% of the stock. Comerica Bank stated it has 26,368 shares or 0.01% of all its holdings.

The chart of Innophos Holdings, Inc. (IPHS) shows a double bottom with $43.11 target or 8.00 % below today’s $46.86 share price. The 6 months chart pattern indicates high risk for the $915.00 million company. It was reported on Sep, 17 by If the $43.11 price target is reached, the company will be worth $73.20M less. Double bottoms are rare but powerful chart patterns.

The stock increased 1.08% or $0.5 on September 15, reaching $46.86. About 199,358 shares traded or 161.41% up from the average. Innophos Holdings, Inc. (NASDAQ:IPHS) has risen 18.50% since September 17, 2016 and is uptrending. It has outperformed by 1.80% the S&P500.

Investors wait Innophos Holdings, Inc. (NASDAQ:IPHS) to report on October, 26. its quarterly earnings Wall Street analysts expect $0.76 EPS, up $0.01 or 1.33 % from last year’s $0.75 same quarter earnings. This translates into $14.84M profit for IPHS giving the stock a 15.41 P/E. This is assuming the current $0.76 EPS is accurate. Innophos Holdings, Inc.’s Wall Street analysts see 33.33 % EPS growth, taking into account the $0.57 EPS reproted in the previous quarter,

Innophos Holdings, Inc. (NASDAQ:IPHS) Ratings Coverage

Among 3 analysts covering Innophos Holdings (NASDAQ:IPHS), 1 have Buy rating, 1 Sell and 1 Hold. Therefore 33% are positive. Innophos Holdings had 6 analyst reports since August 24, 2015 according to SRatingsIntel. On Friday, December 16 the stock rating was downgraded by Sidoti to “Neutral”. Sidoti upgraded the stock to “Buy” rating in Friday, May 26 report. On Thursday, September 3 the stock rating was downgraded by Zacks to “Sell”. The stock of Innophos Holdings, Inc. (NASDAQ:IPHS) earned “Sell” rating by Zacks on Monday, August 24. As per Wednesday, September 6, the company rating was maintained by KeyBanc Capital Markets. Sidoti initiated the shares of IPHS in report on Thursday, October 20 with “Buy” rating.

More notable recent Innophos Holdings, Inc. (NASDAQ:IPHS) news were published by: which released: “Innophos To Acquire Novel Ingredients To Create A Nearly $0.5 Billion Food …” on August 01, 2017, also with their article: “Ex-Dividend Reminder: Visa, United Technologies and Innophos Holdings” published on August 14, 2017, published: “Innophos Holdings, Inc. Appoints Seasoned Global Operations Executive Mark …” on April 27, 2017. More interesting news about Innophos Holdings, Inc. (NASDAQ:IPHS) were released by: and their article: “Self-Improvement Not Quite Enough For Innophos” published on March 21, 2017 as well as‘s news article titled: “Innophos Holdings, Inc. Releases 2016 Quarterly Results Reflecting Previously …” with publication date: May 16, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.